Rev Esp Quimioter 2021; 34(2): 93-99

High level of medication regimen complexity index correlate with worse quality of life in people living with HIV

ENRIQUE CONTRERAS-MACÍAS, ANTONIO GUTIÉRREZ- PIZARRAYA, MARÍA AGUAS ROBUSTILLO-CORTÉS, RAMÓN MORILLO-VERDUGO

Published: 27 January 2021

http://www.doi.org/10.37201/req/097.2020

Objectives. People living with HIV (PLWHIV) have now a near-normal life expectancy and thus, a higher risk of polypharmacy. The main objective was to assess the correlation between medication regimen complexity index (MRCI) and quality of life (EQ-5D) and health utilities among PLWHIV patients on ART.
Patients and methods. Observational prospective single-center study including adult PLWHIV on ART from January to March-2020 attended at hospital pharmacy outpatient service according to a Capacity-Motivation-Opportunity (CMO) pharmaceutical care model.
Results. A total of 428 patients were included, mean age of 50 ± 10.9 years, 82.2% males. Negative correlation (r2=−0.147; p= 0.0002) between MRCI and EQ-5D was found. Relationship between the comorbidity pattern and quality of life, was also observed. Regarding MRCI, Anxiety/Depression, Pain/discomfort and Self-Care were the dimensions with the worst assessment.
Conclusions. A new multidimensional revised care plan for PLWHIV focussed on optimising overall patient care, not limited to viral load goal achievement alone but also in their pharmacotherapeutic complexity and quality of life is needed.

Rev Esp Quimioter 2021; 34(2): 93-99 [Full-text PDF]